| Positive Rankings |
Estimated Revenue Growth
Syndax Pharmaceuticals rank is 132 |
90 Day Gain
Syndax Pharmaceuticals rank is 285 |
10 Day Gain
Syndax Pharmaceuticals rank is 329 |
Debt-to-Equity
Syndax Pharmaceuticals rank is 1261 |
Up EPS Surprise
Syndax Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings. |
| Negative Rankings |
Negative Net Margin
Syndax Pharmaceuticals rank is 85 |
Price-to-Sales
Syndax Pharmaceuticals rank is 85 |
Negative ROE
Syndax Pharmaceuticals rank is 280 |
Negative ROA
Syndax Pharmaceuticals rank is 306 |
Price-to-Book
Syndax Pharmaceuticals rank is 1164 |
